Aristo Bio-Tech and Lifescience (NSE:ARISTO) Cash And Cash Equivalents : ₹6 Mil (As of Mar. 2024)

Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Chart

Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Aristo Bio-Tech and Lifescience Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Aristo Bio-Tech and Lifescience's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Aristo Bio-Tech and Lifescience Business Description